Women with ductal carcinoma in situ (DCIS) who choose bilateral mastectomy…Read more on AuntMinnie.comRelated Reading:
How accurate are DCIS predictions from radiologists?
Overdiagnosis claims not supported, ACR, SBI say
ASTRO: Radiation boost cuts local recurrence in DCIS patients
New treatment guidelines issued for DCIS
Needle biopsy hormone testing unnecessary for DCIS
ConclusionOlder women at risk for MDD before DCIS diagnosis were less likely to receive RT after BCS, compared to BCS alone or mastectomy.
PMID: 30328007 [PubMed – as supplied by publisher]
CONCLUSIONS: This is the first work to systematically catalog the critical features of breast OCT images. The results indicate that OCT can be used to identify and distinguish between benign and malignant features in human breast tissue.
PMID: 30295149 [PubMed – as supplied by publisher]
We present the case of a congenital absence of the system identified from routine preoperative CTA. A 61-year-old female presented for immediate unilateral breast reconstruction following mastectomy for ductal carcinoma in situ. She previously had a right-sided Kocher ’s incision performed for an open cholecystectomy and a gridiron incision. Coincidentally, preoperative CTA demonstrated congenital absence of the left DIEP system, and marked atrophy of the upper right rectus abdominis (RA). As a result, the superior gluteal artery perforator (SGAP) flap was plan ned. Intraoperatively, a 1.318-kg SGAP was raised on thr…
There are limited data evaluating patient satisfaction with their decision to undergo breast conserving surgery (BCS) vs mastectomy for treatment of ductal carcinoma in situ (DCIS).
The last decade has seen a rise in the use of mastectomy for the treatment of ductal carcinoma in situ of the breast (DCIS). We hypothesized that the availability of health resources may influence surgical treatment decisions.
AbstractTreatment for ductal carcinoma in-situ (DCIS) has historically been extrapolated from studies of invasive breast cancer. Accepted local therapy approaches range from small local excisions, with or without radiation, to bilateral mastectomies. Systemic treatment with endocrine therapy is often recommended for hormone positive patients. With improvements in imaging, pathologic review, and treatment techniques in the modern era, combined with new information regarding tumor biology, the management of DCIS is rapidly evolving. A multidisciplinary approach to treatment is now more important than ever, with a shift towar…
This study evaluates population-based outcomes for patients with extensive ( ≥4 centimeters) pure ductal carcinoma in-situ (DCIS). Local recurrence was 2% with mastectomy, 8% with breast conserving surgery (BCS) and radiotherapy and 16% with BCS alone. Mastectomy remains a standard local treatment for extensive DCIS, while BCS and radiotherapy may be reasonably considered in selected patients with a careful discussion of the benefits and side effects.
This study evaluates local relapse according to type of local therapy: mastectomy, breast-conserving surgery (BCS) alone, and BCS + radiation therapy (RT).
Breast reconstruction is an integral part of breast cancer treatment. It must be systematically mentioned when the disease is announced and proposed at an optimal time during cancer management. In case of ductal carcinoma in situ, reconstruction should be proposed at the same time as mastectomy, which generally preserves the skin. The conservation of the nipple-areolar complex should be further evaluated. In the case of invasive breast carcinoma, breast reconstruction is generally proposed at a distance from the oncological time, except for patients requiring neither chemotherapy nor postoperative radioth…